NPM1 and acute myeloid leukemia: Oncogenic mutations were most frequently detected in NPM1, DNMT3A and FLT3 loci and overall, this AML PDX resource recapitulated the genetic abnormalities that are observed in large clinical AML cohorts2 (Fig. 1c).